Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
Public ClinicalTrials.gov record NCT00326339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Dose Ranging Study to Evaluate Up to Three Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II, multicenter, randomized, double-blind, placebo-controlled, ascending dose, dose ranging study to evaluate up to three doses of R935788 (50 mg bid, 100 mg bid and 150 mg bid). Approximately 180 patients who have had rheumatoid arthritis for a minimum of 12 months and who have been receiving a weekly methotrexate (MTX) dose for a minimum of 6 months will be enrolled into the study.
Study identification
- NCT ID
- NCT00326339
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 189 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Sep 30, 2007
- Completion
- Nov 30, 2007
- Last update posted
- Apr 19, 2009
2006 – 2007
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Arthritis Center Medical Group | Santa Maria | California | 93455 | — |
| DMI research | Ocala | Florida | 34471 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Arthritis & Osteoporosis Treatment Center | Orange Park | Florida | 32073 | — |
| Arthritis Associates Inc. | Orlando | Florida | 32804 | — |
| Arthritis Research of Florida, Inc. | Palm Harbor | Florida | 34684 | — |
| Arthritis Research of Florida | Palm Harbor | Florida | 34684 | — |
| Lovelace Scientific Resources | Sarasota | Florida | 34233 | — |
| The Center for Arthritis and Rheumatic Diseas | South Miami | Florida | 33143 | — |
| Coeur d'Alene Arthritis Clinical Trials | Coeur d'Alene | Idaho | 83814-2644 | — |
| The Arthritis Center | Springfield | Illinois | 62704 | — |
| MMG Clinical Research | South Bend | Indiana | 46601 | — |
| Phase III Clinical Research | Fall River | Massachusetts | 02720 | — |
| Michigan Arthritis Research Center | Brighton | Michigan | 48116 | — |
| Westroad Medical Group | Omaha | Nebraska | 68114 | — |
| NC Arthritis & Allergy Care Center | Raleigh | North Carolina | 27609 | — |
| Clinical Research Division | Mayfield Village | Ohio | 44143 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| East Penn Rheumatology Associates | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Ctr. for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Clinical Research Center of Reading LLP | West Reading | Pennsylvania | 19611 | — |
| Low Country Rheumatology | Charleston | South Carolina | 29406 | — |
| Arthritis Clinic | Jackson | Tennessee | 38305 | — |
| SCRI | Memphis | Tennessee | 38115 | — |
| Austin Rheumatology Research | Austin | Texas | 78705 | — |
| Research Across America | El Paso | Texas | 79902 | — |
| Center for Arth. & Rheum. Disease, PC | Chesapeake | Virginia | 23320 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00326339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2009 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00326339 live on ClinicalTrials.gov.